One trend that surfaced in the 2010 Index was an increase in consolidation and partnership. How will this affect overall price?

The increased number of acquisitions and collaborations with generics companies has the potential to drive the price of patented products down by providing originator companies with the low-cost production and distribution capacity of generic firms. However, they might also hamper generic competition following the expiry of product patents.